CDC IXIS has added seven new funds to its 'CDC International Fund' Luxembourg Sicav. The funds ar...
CDC IXIS has added seven new funds to its 'CDC International Fund' Luxembourg Sicav. The funds are all US equity funds, managed by three US-based specialists. The funds are divided into three styles: growth, value and core. The two growth funds to be added will be run by Loomis Sayles & Co. The first will be the CDC Loomis US Large Cap Growth fund and it will be equivalent to the Russell 1000 growth. The second will be the CDC Loomis US Small Cap Growth fund and will focus on medium and small-cap companies ($500m to $1.5bn) generally equivalent to stocks listed in the Russell 2500 Gro...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes